Literature DB >> 31693750

Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints.

Olga Wallis1, Yvonne Bol2, Sebastian Köhler3, Caroline van Heugten3,4,5.   

Abstract

OBJECTIVES: Multiple sclerosis (MS) patients suffer from high levels of anxiety. However, it is unclear which factors are related to anxiety, since study results are inconsistent, and the associated factors have not been examined comprehensively. In this study, we investigated the demographic, disease-related and psychological factors associated with anxiety in MS patients.
MATERIALS AND METHODS: Cross-sectional data of 119 MS patients were used. Anxiety and depressive symptoms (Hospital Anxiety and Depression Scale), fatigue (Fatigue Severity Scale), cognitive complaints (Cognitive Failures Questionnaire) and cognitive functioning (Wisconsin Card Sorting Test, Controlled Oral Word Association Test, Letter Digit Substitution Test, Concept Shifting Test, Wechsler Memory Test Faces and the Dutch version of the California Verbal Learning Test) were measured. Bivariate and multivariable regression analyses were conducted to test the associations between anxiety and potential contributing factors.
RESULTS: In this sample, 42% of the MS patients had clinically significant levels of anxiety, defined by a score ≥8 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS). A significant correlation was found between anxiety and depressive symptoms, fatigue, cognitive complaints and psychiatric history. In the multivariable analysis, only depressive symptoms and cognitive complaints remained significantly related to anxiety.
CONCLUSIONS: Anxiety is common in MS patients and most strongly related to psychological factors. This knowledge can be taken into account when treating patients with MS. Further research is needed using longitudinal designs and incorporating other factors known to influence anxiety, such as coping, negative affectivity and social support.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; cognition; contribute; depression; multiple sclerosis; psychological

Mesh:

Year:  2019        PMID: 31693750     DOI: 10.1111/ane.13191

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a.

Authors:  Hanne van Ballegooijen; Karin van der Hiele; Christian Enzinger; Gert de Voer; Leo H Visser
Journal:  eNeurologicalSci       Date:  2022-06-14

2.  The Role of Cognitive Complaints in the Relationship Between Trait Anxiety, Depressive Symptoms, and Subjective Well-Being and Ill-Being in Adult Community Volunteers.

Authors:  Kuniyoshi Toyoshima; Masahiko Ichiki; Takeshi Inoue; Jiro Masuya; Yota Fujimura; Shinji Higashi; Ichiro Kusumi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-30       Impact factor: 2.570

3.  The Impact of Epigallocatechin Gallate and Coconut Oil Treatment on Cortisol Activity and Depression in Multiple Sclerosis Patients.

Authors:  Jose Luis Platero; María Cuerda-Ballester; David Sancho-Cantus; María Benlloch; Jose Joaquin Ceron; Camila Peres Rubio; María Pilar García-Pardo; María Mar López-Rodríguez; Jose Enrique de la Rubia Ortí
Journal:  Life (Basel)       Date:  2021-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.